UBS Group’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Buy |
311,956
+29,340
| +10% | +$330K | ﹤0.01% | 3360 |
|
|
2025
Q1 | $1.61M | Sell |
282,616
-103,731
| -27% | -$591K | ﹤0.01% | 3843 |
|
|
2024
Q4 | $3.79M | Buy |
386,347
+369,607
| +2,208% | +$3.63M | ﹤0.01% | 3222 |
|
|
2024
Q3 | $136K | Buy |
16,740
+4,925
| +42% | +$40.1K | ﹤0.01% | 4955 |
|
|
2024
Q2 | $158K | Sell |
11,815
-3,450
| -23% | -$46.1K | ﹤0.01% | 4707 |
|
|
2024
Q1 | $708K | Buy |
15,265
+9,725
| +176% | +$451K | ﹤0.01% | 3824 |
|
|
2023
Q4 | $375K | Sell |
5,540
-4,586
| -45% | -$310K | ﹤0.01% | 4179 |
|
|
2023
Q3 | $733K | Buy |
10,126
+3,679
| +57% | +$266K | ﹤0.01% | 3340 |
|
|
2023
Q2 | $480K | Buy |
6,447
+1,516
| +31% | +$113K | ﹤0.01% | 3859 |
|
|
2023
Q1 | $262K | Sell |
4,931
-3,364
| -41% | -$179K | ﹤0.01% | 4157 |
|
|
2022
Q4 | $561K | Buy |
8,295
+635
| +8% | +$42.9K | ﹤0.01% | 3613 |
|
|
2022
Q3 | $956K | Buy |
7,660
+6,044
| +374% | +$754K | ﹤0.01% | 2877 |
|
|
2022
Q2 | $154K | Sell |
1,616
-932
| -37% | -$88.8K | ﹤0.01% | 4128 |
|
|
2022
Q1 | $411K | Buy |
2,548
+2,484
| +3,881% | +$401K | ﹤0.01% | 3884 |
|
|
2021
Q4 | $21K | Buy |
64
+18
| +39% | +$5.91K | ﹤0.01% | 6659 |
|
|
2021
Q3 | $21K | Buy |
+46
| New | +$21K | ﹤0.01% | 5973 |
|